VUMC Limited Submission Opportunity: Translational Cancer Research Grant from the Mary Kay Foundation
Vanderbilt University Medical Center (VUMC) may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2017. These awards provide $100,000 over two years for investigators involved in translational research in ovarian, uterine, breast or cervical cancer.
The Mary Kay Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention or treatment of cancer.
• The foundation anticipates funding between ten and fifteen grants this year.
• Maximum $100,000 award includes direct and indirect costs over a two year period. (Indirects may not exceed 15 percent).
• U.S. citizenship is not required.
Anyone interested in being considered as VUMC’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on Dec. 5.
Brief (two page maximum) research plan including summary budget;
Brief statement of support from department chair/center director;
CV or NIH Biosketch.
Submissions should reference the program name in the subject line of the email.
Once received, all proposals will be forwarded to a VUMC internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the foundation by the Feb. 3, 2017 deadline.
If you have any questions about the foundation or its interests and priorities, please contact one of the following: Adele White, director, VUMC Foundation Relations.